chr19-55159099-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000524407.7(DNAAF3):c.1589C>T(p.Pro530Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,609,198 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P530P) has been classified as Likely benign.
Frequency
Consequence
ENST00000524407.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF3 | NM_001256715.2 | c.1589C>T | p.Pro530Leu | missense_variant | 12/12 | ENST00000524407.7 | NP_001243644.1 | |
DNAAF3 | NM_001256714.1 | c.1790C>T | p.Pro597Leu | missense_variant | 12/12 | NP_001243643.1 | ||
DNAAF3 | NM_178837.4 | c.1730C>T | p.Pro577Leu | missense_variant | 12/12 | NP_849159.2 | ||
DNAAF3 | NM_001256716.2 | c.1427C>T | p.Pro476Leu | missense_variant | 12/12 | NP_001243645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF3 | ENST00000524407.7 | c.1589C>T | p.Pro530Leu | missense_variant | 12/12 | 1 | NM_001256715.2 | ENSP00000432046 | A2 | |
DNAAF3-AS1 | ENST00000591665.1 | n.161G>A | non_coding_transcript_exon_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000808 AC: 123AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00100 AC: 246AN: 245814Hom.: 0 AF XY: 0.00102 AC XY: 136AN XY: 133916
GnomAD4 exome AF: 0.00132 AC: 1929AN: 1456860Hom.: 3 Cov.: 31 AF XY: 0.00132 AC XY: 959AN XY: 724174
GnomAD4 genome AF: 0.000807 AC: 123AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000752 AC XY: 56AN XY: 74500
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 597 of the DNAAF3 protein (p.Pro597Leu). This variant is present in population databases (rs200673226, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DNAAF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 330207). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Primary ciliary dyskinesia 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
DNAAF3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at